Shares of Johnson & Johnson
JNJ,
+1.35%
advanced 1.35% to $170.98 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index
SPX,
+1.19%
rising 1.19% to 3,797.34 and the Dow Jones Industrial Average
DJIA,
+1.34%
rising 1.34% to 31,499.62. This was the stock’s third consecutive day of gains. Johnson & Johnson closed $15.71 below its 52-week high ($186.69), which the company achieved on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Roche Holding AG Part. Cert.
RHHVF,
-1.49%
fell 1.49% to $319.91, Merck & Co. Inc.
MRK,
+1.78%
rose 1.78% to $97.37, and Pfizer Inc.
PFE,
+1.31%
rose 1.31% to $45.54. Trading volume (6.8 M) remained 682,337 below its 50-day average volume of 7.5 M.
Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
